M3 Global Research Attends 2019 ASCO Annual Meeting

We are back from ASCO 2019, which took place from 31 May – 4 June in Chicago, IL.

It was a pleasure to attend one of the largest educational and scientific gatherings of oncology medical professionals as well as to have the chance to meet some of our M3 members face-to-face.

We also met new healthcare professionals who learned more about M3 and medical market research. We are proud to welcome them aboard.

Many thanks to ASCO and everyone who visited our booth to say ‘Hi!’

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.